Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
9
pubmed:dateCreated
2004-8-23
pubmed:abstractText
The objective of the study was to investigate the effect of Follicular-Fluid Meiosis Activating Sterol (FF-MAS) when added to the culture media on the incidence of chromosomal abnormalities and pre-embryo development in human pre-embryos.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0268-1161
pubmed:author
pubmed:issnType
Print
pubmed:volume
19
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2109-17
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:15243006-Adult, pubmed-meshheading:15243006-Blastocyst, pubmed-meshheading:15243006-Blastomeres, pubmed-meshheading:15243006-Cells, Cultured, pubmed-meshheading:15243006-Cholestenes, pubmed-meshheading:15243006-Chromosome Aberrations, pubmed-meshheading:15243006-Cleavage Stage, Ovum, pubmed-meshheading:15243006-Cytogenetic Analysis, pubmed-meshheading:15243006-Cytoplasm, pubmed-meshheading:15243006-Dose-Response Relationship, Drug, pubmed-meshheading:15243006-Double-Blind Method, pubmed-meshheading:15243006-Embryonic Development, pubmed-meshheading:15243006-Female, pubmed-meshheading:15243006-Fertilization, pubmed-meshheading:15243006-Fertilization in Vitro, pubmed-meshheading:15243006-Follicular Fluid, pubmed-meshheading:15243006-Humans, pubmed-meshheading:15243006-Metaphase, pubmed-meshheading:15243006-Mosaicism, pubmed-meshheading:15243006-Oocytes, pubmed-meshheading:15243006-Osmolar Concentration
pubmed:year
2004
pubmed:articleTitle
Chromosomal abnormality rate in human pre-embryos derived from in vitro fertilization cycles cultured in the presence of Follicular-Fluid Meiosis Activating Sterol (FF-MAS).
pubmed:affiliation
Reproductive Medicine, Department of Obstetrics and Gynecology, Sahlgrenska University Hospital, Göteborg, Sweden. christina.bergh@vgregion.se
pubmed:publicationType
Journal Article, Clinical Trial, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study, Clinical Trial, Phase I